Selected papers from the Editorial Board| Volume 91, P10-19, April 2023

A Systematic Review and Meta-Analysis to Assess the Impact of Pre-existing Comorbidities on the 30-Day Readmission after Lower Extremity Bypass Surgery for Peripheral Artery Occlusive Disease

Published:December 19, 2022DOI:


      Unplanned hospital readmissions after surgical operations are considered a marker for suboptimal care during index hospitalizations and are associated with poor patient outcomes and increased healthcare resource utilization. Patients undergoing lower extremity bypass (LEB) operations for severe peripheral arterial disease (PAD) have one of the highest readmission rates, among all the vascular and nonvascular surgical operations. This review is meant to evaluate the impact of pre-existing comorbidities (diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), hypertension (HTN), and coronary artery disease (CAD))—on the 30-day readmission rates among patients who underwent LEB for severe PAD.


      The review protocol was registered to the PROSPERO database (CRD42021261067). A systematic review of the English literature was performed using PubMed, Scopus, and the Cochrane Library databases from inception till April 2022. The review was based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines and included only studies reporting on 30-day readmission following LEB for occlusive PAD. The quality of evidence was assessed using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach and was reported as high, moderate, or low. The risk of bias was evaluated utilizing the Risk of Bias in Nonrandomized Studies - of Interventions (ROBINS-I) tool. A pooled odds ratio (OR) for each study was computed, and a P-value of <0.05 was designated as statistically significant. Interstudy heterogeneity was evaluated by Q-metric and quantified using Higgins I2 statistics.


      Five studies reported data on 30-day readmission after LEB for occlusive PAD. A total of 19,739 patients were included. Readmission occurred among 3,559 (18%) patients. DM and COPD were reported by all 5 selected studies, and CHF and HTN were reported by 4 studies. CAD was least reported among the selected 5 pre-existing conditions, with only 2 studies mentioning it. HTN (OR, 1.35; 95% confidence interval (CI), 1.10–1.64; P ≤ 0.001; I2 = 52.20%), DM (OR, 1.52; 95% CI, 1.30–1.79; P ≤ 0.001; I2 = 74.51%), and CHF (OR, 1.85; 95% CI, 1.51–2.25; P ≤ 0.001; I2 = 50.48%) were all found to be associated with an increased risk of 30-day readmission, while the presence of COPD (OR, 1.16; 95% CI, 0.98–1.36; P = 0.09; I2 = 61.93%) and CAD (OR, 1.30; 95% CI, 0.94–1.78; P = 0.11; I2 = 51.01%) was not associated with early readmission on meta-analysis of the available studies.


      The pre-existing comorbidities HTN, DM, and CHF increase the risk of 30-day readmission after LEB for occlusive PAD. The identification of these risk factors can help stratify the patients and further guide in understanding the variety of factors that contribute in hospital readmissions.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Annals of Vascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Teo K.
        • Yong C.W.
        • Chuah J.H.
        • et al.
        Current trends in readmission prediction: an overview of approaches.
        Arab J Sci Eng. 2021; : 1-18
      1. AHRQ overview of clinical conditions with frequent and costly hospital readmissions by payer, 2018.
        • Glebova N.O.
        • Bronsert M.
        • Hammermeister K.E.
        • et al.
        Drivers of readmissions in vascular surgery patients.
        J Vasc Surg. 2016; 64: 185-194.e3
        • Fischer C.
        • Lingsma H.F.
        • Marang-van de Mheen P.J.
        • et al.
        Is the readmission rate a valid quality indicator? A review of the evidence.
        PLoS One. 2014; 9: e112282
        • Fein I.A.
        Readmissions as a quality metric: ready for prime time?.
        Crit Care Med. 2018; 46: 821-823
        • Clarke A.
        Readmission to hospital: a measure of quality or outcome?.
        Qual Saf Health Care. 2004; 13: 10-11
        • Wiseman J.T.
        • Guzman A.M.
        • Fernandes-Taylor S.
        • et al.
        General and vascular surgery readmissions: a systematic review.
        J Am Coll Surg. 2014; 219: 552-569.e2
        • Aday A.W.
        • Matsushita K.
        Epidemiology of peripheral artery disease and polyvascular disease.
        Circ Res. 2021; 128: 1818-1832
        • Kolte D.
        • Kennedy K.F.
        • Shishehbor M.H.
        • et al.
        Thirty-day readmissions after endovascular or surgical therapy for critical limb ischemia: analysis of the 2013 to 2014 nationwide readmissions databases.
        Circulation. 2017; 136: 167-176
        • Krafcik B.M.
        • Komshian S.
        • Lu K.
        • et al.
        Short- and long-term readmission rates after infrainguinal bypass in a safety net hospital are higher than expected.
        J Vasc Surg. 2017; 66: 1786-1791
        • Vogel T.R.
        • Kruse R.L.
        Risk factors for readmission after lower extremity procedures for peripheral artery disease.
        J Vasc Surg. 2013; 58 (97.e1-4): 90
        • Richardson W.S.
        • Wilson M.C.
        • Nishikawa J.
        • et al.
        The well-built clinical question: a key to evidence-based decisions.
        ACP J Club. 1995; 123: A12-A13
        • Liberati A.
        • Altman D.G.
        • Tetzlaff J.
        • et al.
        The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
        BMJ. 2009; 339: b2700
        • Schunemann H.J.
        • Oxman A.D.
        • Brozek J.
        • et al.
        Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.
        BMJ. 2008; 336: 1106-1110
        • Schünemann H.B.J.
        • Guyatt G.
        • Oxman A.
        GRADE handbook for grading quality of evidence and strength of recommendations.
        • Sterne J.A.
        • Hernan M.A.
        • Reeves B.C.
        • et al.
        ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
        BMJ. 2016; 355: i4919
      2. StatsDirect heterogeneity in meta-analysis.
        • Damrauer S.M.
        • Gaffey A.C.
        • DeBord Smith A.
        • et al.
        Comparison of risk factors for length of stay and readmission following lower extremity bypass surgery.
        J Vasc Surg. 2015; 62: 1192-1200.e1
        • Zhang J.Q.
        • Curran T.
        • McCallum J.C.
        • et al.
        Risk factors for readmission after lower extremity bypass in the American college of surgeons national surgery quality improvement program.
        J Vasc Surg. 2014; 59: 1331-1339
        • Aziz F.
        • Lehman E.B.
        • Reed A.B.
        Unplanned return to operating room after lower extremity arterial bypass is an independent predictor for hospital readmission.
        J Vasc Surg. 2016; 63: 678-687.e2
        • Bluemn E.G.
        • Flahive J.M.
        • Farber A.
        • et al.
        Analysis of thirty-day readmission after infrainguinal bypass.
        Ann Vasc Surg. 2019; 61: 34-47
        • Dua A.
        • Lee C.J.
        Epidemiology of peripheral arterial disease and critical limb ischemia.
        Tech Vasc Interv Radiol. 2016; 19: 91-95
        • Conte M.S.
        • Pomposelli F.B.
        • et al.
        • Society for Vascular Surgery Lower Extremity Guidelines Writing Group
        Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.
        J Vasc Surg. 2015; 61: 2S-41S
        • McPhee J.T.
        • Nguyen L.L.
        • Ho K.J.
        • et al.
        Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia.
        J Vasc Surg. 2013; 57: 1481-1488
        • Jones C.E.
        • Richman J.S.
        • Chu D.I.
        • et al.
        Readmission rates after lower extremity bypass vary significantly by surgical indication.
        J Vasc Surg. 2016; 64: 458-464
        • Secemsky E.A.
        • Schermerhorn M.
        • Carroll B.J.
        • et al.
        Readmissions after revascularization procedures for peripheral arterial disease.
        Ann Intern Med. 2017; 168: 93-99
        • Orr N.T.
        • El-Maraghi S.
        • Korosec R.L.
        • et al.
        Cost analysis of vascular readmissions after common vascular procedures.
        J Vasc Surg. 2015; 62: 1281-1287.e1
        • Jencks S.F.
        • Williams M.V.
        • Coleman E.A.
        Rehospitalizations among patients in the Medicare fee-for-service program.
        N Engl J Med. 2009; 360: 1418-1428
        • Duwayri Y.
        • Goss J.
        • Knechtle W.
        • et al.
        The readmission event after vascular surgery: causes and costs.
        Ann Vasc Surg. 2016; 36: 7-12
        • Mehtsun W.T.
        • Papanicolas I.
        • Zheng J.
        • et al.
        National trends in readmission following inpatient surgery in the hospital readmissions reduction program era.
        Ann Surg. 2018; 267: 599-605
        • Ibrahim A.M.
        • Nathan H.
        • Thumma J.R.
        • et al.
        Impact of the hospital readmission reduction program on surgical readmissions among Medicare beneficiaries.
        Ann Surg. 2017; 266: 617-624
        • Smith S.L.
        • Matthews E.O.
        • Moxon J.V.
        • et al.
        A systematic review and meta-analysis of risk factors for and incidence of 30-day readmission after revascularization for peripheral artery disease.
        J Vasc Surg. 2019; 70: 996-1006.e7
        • Latz C.A.
        • Wang L.J.
        • Boitano L.
        • et al.
        Unplanned readmissions after endovascular intervention or surgical bypass for critical limb ischemia.
        J Vasc Surg. 2021; 73: 942-949.e1
        • Medina D.
        • Zil-E-Ali A.
        • Daoud D.
        • et al.
        Implementation of transitional care planning is associated with reduced readmission rates in patients undergoing lower extremity bypass surgery for peripheral arterial disease.
        Ann Vasc Surg. 2022; 84: 28-39
        • Knighton A.
        • Martin G.
        • Sounderajah V.
        • et al.
        Avoidable 30-day readmissions in patients undergoing vascular surgery.
        BJS Open. 2019; 3: 759-766
        • Gupta P.K.
        • Fernandes-Taylor S.
        • Ramanan B.
        • et al.
        Unplanned readmissions after vascular surgery.
        J Vasc Surg. 2014; 59: 473-482
        • Natesan S.
        • Li J.Y.
        • Kyaw K.K.
        • et al.
        Effectiveness of comanagement model: geriatric medicine and vascular surgery.
        J Am Med Dir Assoc. 2022; 23: 666-670
        • Banning L.B.D.
        • El Moumni M.
        • Visser L.
        • et al.
        Frailty leads to poor long-term survival in patients undergoing elective vascular surgery.
        J Vasc Surg. 2021; 73: 2132-2139.e2
        • Czobor N.R.
        • Lehot J.J.
        • Holndonner-Kirst E.
        • et al.
        Frailty in patients undergoing vascular surgery: a narrative review of current evidence.
        Ther Clin Risk Manag. 2019; 15: 1217-1232
        • Galyfos G.
        • Geropapas G.I.
        • Kerasidis S.
        • et al.
        The effect of body mass index on major outcomes after vascular surgery.
        J Vasc Surg. 2017; 65: 1193-1207
        • Arinze N.
        • Farber A.
        • Levin S.R.
        • et al.
        Perioperative outcomes after lower extremity bypass and peripheral vascular interventions in patients with morbid obesity and superobesity.
        J Vasc Surg. 2020; 71: 567-574.e4
        • Tadros R.O.
        • Png C.Y.M.
        • Lau I.H.
        • et al.
        Defining types and determining risk factors for vascular surgery readmissions.
        Ann Vasc Surg. 2019; 55: 222-231